Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

NCT01115855 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Eplerenone
DRUG: Placebo

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.